Flemming Ornskov Purchases 8,400 Shares of Shire PLC (SHP) Stock
Shire PLC (LON:SHP) insider Flemming Ornskov acquired 8,400 shares of Shire PLC stock in a transaction that occurred on Tuesday, August 22nd. The stock was acquired at an average cost of GBX 3,665 ($47.58) per share, for a total transaction of £307,860 ($399,662.47).
Shares of Shire PLC (LON SHP) traded up 3.10% during midday trading on Tuesday, reaching GBX 3725.00. 2,856,092 shares of the company’s stock were exchanged. The firm has a 50-day moving average of GBX 4,102.40 and a 200-day moving average of GBX 4,499.20. Shire PLC has a 12-month low of GBX 3,603.50 and a 12-month high of GBX 5,377.00. The stock’s market capitalization is GBX 33.76 billion.
The company also recently announced a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be issued a GBX 3.85 ($0.05) dividend. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.1%.
COPYRIGHT VIOLATION WARNING: “Flemming Ornskov Purchases 8,400 Shares of Shire PLC (SHP) Stock” was posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/08/22/flemming-ornskov-purchases-8400-shares-of-shire-plc-shp-stock.html.
Several research firms recently issued reports on SHP. Barclays PLC restated an “overweight” rating and issued a GBX 6,300 ($81.79) target price on shares of Shire PLC in a report on Monday, July 3rd. Beaufort Securities restated a “long term buy” rating and issued a GBX 4,900 ($63.61) target price (down previously from GBX 6,200 ($80.49)) on shares of Shire PLC in a report on Friday, August 4th. J P Morgan Chase & Co restated an “overweight” rating and issued a GBX 6,000 ($77.89) target price on shares of Shire PLC in a report on Friday, May 19th. Credit Suisse Group restated an “outperform” rating and issued a GBX 5,400 ($70.10) target price on shares of Shire PLC in a report on Wednesday, May 3rd. Finally, Deutsche Bank AG restated a “buy” rating and issued a GBX 6,100 ($79.19) target price on shares of Shire PLC in a report on Friday, May 19th. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of GBX 5,896.12 ($76.54).
About Shire PLC
Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.